Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD33 (Gemtuzumab Biosimilar) antibody

The Humanized Monoclonal anti-CD33 (Gemtuzumab Biosimilar) antibody has been validated for FACS. It is suitable to detect CD33 (Gemtuzumab Biosimilar) in samples from Human.
Catalog No. ABIN6964428
-15% Promotion 2026
$248.57
$292.43
save $43.86 (-15 %)
Plus shipping costs $50.00
Shipping to: United States
Delivery in 12 to 14 Business Days

Quick Overview for Recombinant CD33 (Gemtuzumab Biosimilar) antibody (ABIN6964428)

Target

CD33 (Gemtuzumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 3
  • 1
  • 1
  • 1
  • 1
Humanized

Clonality

  • 4
  • 3
Monoclonal

Conjugate

  • 6
  • 1
This CD33 (Gemtuzumab Biosimilar) antibody is un-conjugated

Application

  • 5
  • 3
  • 1
  • 1
Flow Cytometry (FACS)

Grade

Research Grade
  • Purpose

    Anti-CD33 (gemtuzumab biosimilar) mAb

    Characteristics

    CDP-771, CMA-676, WAY-CMA-676,

    Purification

    Purified from cell culture supernatant by affinity chromatography

    Isotype

    IgG4
  • Application Notes

    Flow Cyt 1:100

    Comment

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitute with deionized water

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Expiry Date

    12 months
  • Target

    CD33 (Gemtuzumab Biosimilar)

    Target Type

    Biosimilar

    Background

    Synonyms: CD33,SIGLEC3,gp67

    UniProt

    P20138
You are here:
Chat with us!